ERBB2 and neoplasm: To evaluate the improvement in model performance by incorporating the PIV indicator, this study compared a six-indicator combined predictive model that includes PIV with a traditional model based only on clinicopathological variables (ER, Her2, tumor diameter, clinical nodal stage, and chemotherapy regimen).